No Data
Wells Fargo Maintains Solventum(SOLV.US) With Hold Rating, Raises Target Price to $73
Solventum Faces Activist Shareholder Pressure to Improve Performance
Trian Says Solventum's Dental Solutions, Health Info Systems and Purification & Filtration Segments Are Strategically Different Than Core MedSurg Segment
Solventum Stock Jumps as Activist Investor Weighs In -- Barrons.com
Express News | Trian: Solventum Should Raise Investments in Growth, Fund Those With Savings From Right Sizing Overhead Structure, Increasing Focus, Accountability
Express News | Trian -Believes Solventum Can Perform Better as Independent Company